Gregoire Sylvie
SEC Form 4 insider trading activity
Gregoire Sylvie has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Nov 19, 2025.
On the most recent filing, Gregoire Sylvie is listed as Director, 10% Owner at CervoMed Inc. Inside the rolling window, Gregoire Sylvie reported 4 open-market purchases totaling $283K in CRVO and no open-market sales. The largest disclosed transaction in the window is a purchase of 21,600 CRVO shares on Nov 17, 2025, worth $183K.
Companies traded
Other insiders at CRVO
Insider Buying
$283K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gregoire Sylvie made?
Gregoire Sylvie has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Gregoire Sylvie trade?
Gregoire Sylvie has filed SEC Form 4 disclosures for 1 company, including CRVO.
When was Gregoire Sylvie's most recent SEC Form 4 filing?
Gregoire Sylvie's most recent SEC Form 4 filing on Tracefour is dated Nov 19, 2025.
What is Gregoire Sylvie's total buy and sell value in the current window?
Inside the rolling retention window, Gregoire Sylvie bought $283K and sold $0 based on SEC Form 4 filings.
What was Gregoire Sylvie's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 21,600 CRVO shares on 2025-11-17, worth $183K, per SEC Form 4 filings.